Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $143
Merck & Co., Inc. +0.46%
Merck & Co., Inc. MRK | 126.42 | +0.46% |
Truist Securities analyst Robyn Karnauskas maintains Merck & Co (NYSE:
MRK) with a Buy and raises the price target from $142 to $143.